Skip to main content

Military Health System

COVID-19 Convalescent plasma collection continues

Image of Three units of CCP laying on a table. The COVID-19 Convalescent Plasma, or CCP, collection campaign was a significant success in 2020. The DOD surpassed its goal by collecting more than 10,000 CCP units. The collection of CCP will to continue next year as well. (Photo by Jaciyn Matanane, Naval Hospital Guam.)

Recommended Content:

Coronavirus & the MHS Response | Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine | Armed Services Blood Program

The Defense Health Agency’s COVID-19 Convalescent Plasma, or CCP, collection was a significant success in 2020, exceeding its goal and helping more than 200 Department of Defense beneficiaries who had been hospitalized with the deadly disease.

The DOD campaign resulted in the acquisition of 10,745 units of the plasma donated by active-duty personnel, military retirees, their families, and non-DOD civilians who were designated as fully recovered from COVID-19. The goal of the secretary’s campaign, which ended Sept. 30, had been to collect 10,000 CCP units.

The Defense Health Agency (DHA) launched this donation drive on June 1 through its more than 20 Armed Services Blood Program (ASBP) centers across the continental United States and overseas to collect plasma to support the development of an effective treatment for those seriously ill with the virus.

As of Nov. 30, 204 patients within the MHS had been transfused 322 units of CCP, said ASBP Division Chief Army Col. Audra Taylor. Typically, one or two units are administered to each patient. At the outset of COVID, when CCP became available as an investigational product by the Food and Drug Administration, the treatment was for severely ill patients.

“Since those early days, the recommendations for treatment are earlier,” Taylor noted.

Almost all patients who require supplemental oxygen now also get CCP, noted Air Force Col. Stacy Shackelford, Joint Trauma System chief.

The immune system of a COVID-19-positive patient creates infection-fighting antibodies contained in their plasma. Plasma with these infection-fighting antibodies is called "convalescent plasma." By donating blood or plasma, a patient who has recovered fully provides CCP rich in antibodies to a sick patient who is still fighting the virus to boost their immune system and help them recover.

Female technician making sure bags of CCP are secure
Navy Hospital Corpsman 3rd Class Bailey Carter, assigned to U.S. Naval Hospital Guam, secures blood donations collected from sailors who recovered from COVID-19 this spring. The DOD surpassed its goal by collecting more than 10,000 CCP units. (Photo by Jaciyn Matanane, Naval Hospital Guam.)

Since the close of the initial CCP drive, the Armed Services Blood Program (ASBP) has transitioned to a plan to ensure adequate supplies of CCP for future DOD beneficiaries.

“The ASBP recruiters and blood donor centers continue to use the tools and processes developed for the recruitment of potential donors to support the sustainment of the Department of Defense CCP inventory,” Taylor said, adding that “the designated inventory levels sustain the Military Health System, including the combatant commands.”

Unfortunately, CCP has a one-year shelf life, so collected units will begin to expire in 2021.

Therefore, there is no end date for collection, Taylor noted. A new CCP collection challenge comes with the new COVID-19 vaccines, which, when approved by FDA and distributed for vaccination, will “have an impact on the availability of potential donors as the vaccines come with a deferral period,” she explained.

At a Nov. 16 ceremony honoring the success of the CCP drive, Army Lt. Gen. (Dr.) Ronald Place, director of the Defense Health Agency, said: “In my opinion, that’s the best kind of outcome for our health system.”

The reforms to military medicine remain inspired by the belief that a well-integrated organization across functions, across military departments, and unified in its strategic execution, both internally and with our partners in civilian medicine, strengthens the health and readiness of our force, he explained.

To donate convalescent plasma, donors must meet basic donation requirements. Donations can be done through whole blood or apheresis, a form of plasma collection.

To qualify for the program, participants must:

  • Have evidence of COVID-19 documented by two FDA-approved serological tests for SARS-CoV-2 antibodies after recovery, if prior diagnostic testing was not performed at the time COVID-19 was suspected.
  • Have a complete resolution of symptoms at least 14 days before donation.
  • Undergo potential additional testing if ever pregnant to determine if HLA antibodies have developed.

The DOD’s primary goals against the pandemic are to protect its people, maintain readiness and support the national COVID-19 response. In addition to aiding in the development of new therapeutic treatments for COVID-19-positive patients in DOD facilities, CCP contributes to the overall efforts to combat the disease, thus helping accomplish each of those goals.

You also may be interested in...

COVID-19: Bivalent Booster, New

Infographic
9/19/2022
COVID-19: Bivalent Booster, New

New Booster for Fall!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bivalent Booster, Get Boosted

Infographic
9/19/2022
COVID-19: Bivalent Booster, Get Boosted

Get Boosted!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bivalent Boosters

Infographic
9/19/2022
COVID-19: Bivalent Boosters

COVID-19 Bivalent Booster are now available!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bivalent Booster, Did you know?

Infographic
9/19/2022
COVID-19: Bivalent Booster, Did you know?

Updated COVID-19 Boosters available!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19: Bottom Line on Boosters

Infographic
9/19/2022
COVID-19: Bottom Line on Boosters

Bottom Line on Boosters: Stay up to date!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

DHA Form 207: COVID-19 Vaccine Screening and Immunization Document v22

Form/Template
9/9/2022

The purpose of this form is to determine if the COVID-19 vaccine can be administered to the patient. (v22, Sept. 2022)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Immunization Healthcare Division | COVID-19 Vaccine Efforts | COVID-19 Information for Military Treatment Facility Directors | Coronavirus

Blood Recipient ‘Keeps On’ Telling Others About the Impact Donors Make

Article Around MHS
9/1/2022
Vanessa Aguilar donating blood

Vanessa Aguilar is the ASBP blood donor recruiter at U.S. Navy Medicine Readiness and Training Command Guam Blood Donor Center (US NMRTCG BDC). 

Recommended Content:

Armed Services Blood Program

Novavax COVID-19 Vaccine Now Available for 12 to 17 Year-Olds

Article
8/30/2022
Air Force Staff. Sgt. fills a syringe with a COVID-19 vaccine at Ramstein Air Base, Germany.

Novavax COVID-19 Vaccine is Available for Those 12 Years' Old and Above

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

New COVID-19 Boosters Against Subvariants Coming Soon

Article
8/29/2022
Marine on right gets a COVID-19 booster vaccination from a nursing student on his left.

Brooklyn Marine gets COVID-19 booster vaccination.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

How to Get Your Kids Up to Date on Vaccinations

Article
8/25/2022
Child wearing a mask getting the COVID-19 vaccine

Resources to help you get and keep your child’s immunizations up to date in time for back to school.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Back to School Immunizations | Immunization Healthcare Division

COVID-19 Novavax Vaccine

Infographic
8/18/2022
COVID-19 Novavax Vaccine

The Novavax COVID-19 Vaccine, Adjuvanated includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Types of COVID-19 Vaccines

COVID-19 Vaccines

Infographic
8/18/2022
COVID-19 Vaccines

How COVID-19 Vaccines Work – There are three types of vaccines currently available: mRNA, subunit protein, and viral vector. Pfizer and Moderna are mRNA vaccine. Novavax is a subunit protein vaccine. Janssen is a viral vector vaccine. All products resemble a virus for the immune system to fight.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

COVID-19 Moderna and Pfizer Vaccines

Publication
8/17/2022

Moderna and Pfizer mRNA vaccines are available. Moderna includes two doses, 28 days apart. Pfizer includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Moderna Vaccine

Publication
8/17/2022

Moderna and mRNA vaccines are available. Moderna includes two doses, 28 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 36
Refine your search
Last Updated: August 23, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery